Zidovudine and Perinatal Human Immunodeficiency Virus Type 1 Transmission: A Population-Based Approach
- 1 April 2002
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 109 (4) , e60
- https://doi.org/10.1542/peds.109.4.e60
Abstract
Objective. This study examined the impact of the full 3-arm zidovudine regimen on the perinatal transmission of human immunodeficiency virus type 1 (HIV-1) using population-based data. Methods. We retrospectively ascertained information on zidovudine prescription and other characteristics of HIV-infected pregnant women and children for birth cohort years 1993, 1995, 1996, and 1997 using HIV/acquired immunodeficiency syndrome registry data from a state health department supplemented by medical record reviews. Results. The transmission rate decreased from 12.5% in 1993 to 4.6% in 1997. The proportions of HIV-1-infected mothers and children who were prescribed all 3 arms of zidovudine increased from 68% in 1995 to 93% in 1997. Unadjusted and adjusted odds ratios for the relationship between the prescription of 3 arms of zidovudine and the infants’ HIV status were 0.19 (95% confidence interval: 0.05–0.84) and 0.15 (95% confidence interval: 0.02–0.96), respectively. Conclusion. Perinatal HIV-1 transmission rates have decreased over time. This study demonstrates the effectiveness of the rapid implementation of the United States Public Health Service recommendations for the comprehensive use of zidovudine among HIV-1-infected pregnant women in a predominantly rural state.Keywords
This publication has 20 references indexed in Scilit:
- Abbreviated Regimens of Zidovudine Prophylaxis and Perinatal Transmission of the Human Immunodeficiency VirusNew England Journal of Medicine, 1998
- Impact of zidovudine use on risk and risk factors for perinatal transmission of HIVAIDS, 1998
- After AIDS Clinical Trial 076: The Changing Pattern of Zidovudine Use during Pregnancy, and the Subsequent Reduction in the Vertical Transmission of Human Immunodeficiency Virus in a Cohort of Infected Women and Their InfantsThe Journal of Infectious Diseases, 1996
- Zidovudine use to reduce perinatal HIV type 1 transmission in an urban medical centerPublished by American Medical Association (AMA) ,1996
- Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban countiesPublished by American Medical Association (AMA) ,1996
- Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral loadJAMA, 1996
- Prevalence and incidence of vertically acquired HIV infection in the United StatesPublished by American Medical Association (AMA) ,1995
- Efficacy of Antenatal Zidovudine in Reducing Perinatal Transmission of Human Immunodeficiency Virus Type 1The Journal of Infectious Diseases, 1995
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994
- Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or deliveryPublished by American Medical Association (AMA) ,1994